BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37936057)

  • 1. Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition.
    Lantz C; Lopez J; Goring AK; Zenaidee MA; Biggs K; Whitelegge JP; Ogorzalek Loo RR; Klärner FG; Schrader T; Bitan G; Loo JA
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2739-2747. PubMed ID: 37936057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native Top-Down Mass Spectrometry and Ion Mobility Spectrometry of the Interaction of Tau Protein with a Molecular Tweezer Assembly Modulator.
    Nshanian M; Lantz C; Wongkongkathep P; Schrader T; Klärner FG; Blümke A; Despres C; Ehrmann M; Smet-Nocca C; Bitan G; Loo JA
    J Am Soc Mass Spectrom; 2019 Jan; 30(1):16-23. PubMed ID: 30062477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for preventing α-synuclein aggregation by a molecular tweezer.
    Acharya S; Safaie BM; Wongkongkathep P; Ivanova MI; Attar A; Klärner FG; Schrader T; Loo JA; Bitan G; Lapidus LJ
    J Biol Chem; 2014 Apr; 289(15):10727-10737. PubMed ID: 24567327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein.
    Wongkongkathep P; Han JY; Choi TS; Yin S; Kim HI; Loo JA
    J Am Soc Mass Spectrom; 2018 Sep; 29(9):1870-1880. PubMed ID: 29951842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.
    Bengoa-Vergniory N; Faggiani E; Ramos-Gonzalez P; Kirkiz E; Connor-Robson N; Brown LV; Siddique I; Li Z; Vingill S; Cioroch M; Cavaliere F; Threlfell S; Roberts B; Schrader T; Klärner FG; Cragg S; Dehay B; Bitan G; Matute C; Bezard E; Wade-Martins R
    Nat Commun; 2020 Sep; 11(1):4885. PubMed ID: 32985503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational dynamics of α-synuclein: insights from mass spectrometry.
    Phillips AS; Gomes AF; Kalapothakis JM; Gillam JE; Gasparavicius J; Gozzo FC; Kunath T; MacPhee C; Barran PE
    Analyst; 2015 May; 140(9):3070-81. PubMed ID: 25756329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.
    Richter F; Subramaniam SR; Magen I; Lee P; Hayes J; Attar A; Zhu C; Franich NR; Bove N; De La Rosa K; Kwong J; Klärner FG; Schrader T; Chesselet MF; Bitan G
    Neurotherapeutics; 2017 Oct; 14(4):1107-1119. PubMed ID: 28585223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top/Middle-Down Characterization of α-Synuclein Glycoforms.
    Miller SA; Jeanne Dit Fouque K; Hard ER; Balana AT; Kaplan D; Voinov VG; Ridgeway ME; Park MA; Anderson GA; Pratt MR; Fernandez-Lima F
    Anal Chem; 2023 Dec; 95(49):18039-18045. PubMed ID: 38047498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.
    Prabhudesai S; Sinha S; Attar A; Kotagiri A; Fitzmaurice AG; Lakshmanan R; Ivanova MI; Loo JA; Klärner FG; Schrader T; Stahl M; Bitan G; Bronstein JM
    Neurotherapeutics; 2012 Apr; 9(2):464-76. PubMed ID: 22373667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
    Herrera-Vaquero M; Bouquio D; Kallab M; Biggs K; Nair G; Ochoa J; Heras-Garvin A; Heid C; Hadrovic I; Poewe W; Wenning GK; Klärner FG; Schrader T; Bitan G; Stefanova N
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165513. PubMed ID: 31319154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to α-Synuclein.
    Konijnenberg A; Ranica S; Narkiewicz J; Legname G; Grandori R; Sobott F; Natalello A
    Anal Chem; 2016 Sep; 88(17):8468-75. PubMed ID: 27467405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
    Mason RJ; Paskins AR; Dalton CF; Smith DP
    Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn.
    Lothian A; Lago L; Mukherjee S; Connor AR; Fowler C; McLean CA; Horne M; Masters CL; Cappai R; Roberts BR
    Metallomics; 2019 Jan; 11(1):128-140. PubMed ID: 30465671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of native α-synuclein conformers in the human brain.
    Gould N; Mor DE; Lightfoot R; Malkus K; Giasson B; Ischiropoulos H
    J Biol Chem; 2014 Mar; 289(11):7929-34. PubMed ID: 24474688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Tucholski T; Knott SJ; Chen B; Pistono P; Lin Z; Ge Y
    Anal Chem; 2019 Mar; 91(6):3835-3844. PubMed ID: 30758949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules.
    Hsieh CJ; Ferrie JJ; Xu K; Lee I; Graham TJA; Tu Z; Yu J; Dhavale D; Kotzbauer P; Petersson EJ; Mach RH
    ACS Chem Neurosci; 2018 Nov; 9(11):2521-2527. PubMed ID: 29750499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms.
    Tucholski T; Ge Y
    Mass Spectrom Rev; 2022 Mar; 41(2):158-177. PubMed ID: 32894796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
    Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
    J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.